The article you requested is
Dr. Nemeroff and the Publishers Reply
J Clin Psychiatry 1997;58:452 [letter]
Copyright 1997 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
- Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: There is little doubt that it makes sense and is right for
readers of The Journal of Clinical Psychiatry (JCP) or for that
matter, any journal, to be aware that a journal supplement is
supported by an unrestricted educational grant from the pharmaceutical
industry. I take no issue with this recommendation
and heartily endorse it.
However, I do take issue with several of the other comments
made by Jefferson, Greist, and Katzelnick in the space above. In
particular, I take strong exception to the implication that my article
published in JCP was influenced by a pharmaceutical
sponsor. This is simply not the case, and frankly I am surprised
that such experienced psychopharmacologists as Jefferson and
Greist would take such a position.